QA: MyMD Pharmaceuticals Inc. in us_medicinal_products/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001321834_2023_MyMD_Pharmaceuticals_Inc.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.4089941024350515, 'aggregate_val': 17539980, 'exp_sum': 29678181, 'exp_to_value': {'AssetsCurrent': 5401779, 'AssetsNoncurrent': 12138201, 'PropertyPlantAndEquipmentNet': 0, 'Goodwill': 10498539, 'remainder_Assets': 1639662}}

Graph

Absolute values for 0001321834, MyMD Pharmaceuticals Inc.

  xvar xval
0 LiabilitiesNoncurrent 75,941
1 LiabilitiesCurrent 2,768,983
2 remainder_Liabilities 0
3 AssetsCurrent 5,401,779
4 AssetsNoncurrent 12,138,201
5 PropertyPlantAndEquipmentNet 0
6 Goodwill 10,498,539
7 remainder_Assets -10,498,539
8 GeneralAndAdministrativeExpense 5,520,150
9 ResearchAndDevelopmentExpense 9,067,422
10 remainder_Expenses 695,191
11 remainder_Revenues 0
12 remainder_NetIncome 85,427
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Liabilities 2,844,924
1 Assets 17,539,980
2 Expenses 15,282,763
3 Revenues 0
4 StockholdersEquity 14,695,056
5 NetIncome -15,197,336
6 ComprehensiveNetIncome -15,197,336
7 BaseVar 17,876,547
8 EconomicCapitalRatio -0.266

Edgar->Model Mapping

Feature Distribution

Change over Time